2014
DOI: 10.1021/jm501640e
|View full text |Cite
|
Sign up to set email alerts
|

SAR Studies on Tetrahydroisoquinoline Derivatives: The Role of Flexibility and Bioisosterism To Raise Potency and Selectivity toward P-glycoprotein

Abstract: The development of P-glycoprotein (P-gp) ligands remains of considerable interest, mostly for investigating the protein's structure and transport mechanism. In recent years, many different generations of ligands have been tested for their ability to modulate P-gp activity. The aim of the present work is to perform SAR studies on tetrahydroisoquinoline derivatives in order to design potent and selective P-gp ligands. For this purpose, the effect of bioisosteric replacement and the role of flexibility have been … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 26 publications
(44 citation statements)
references
References 26 publications
1
43
0
Order By: Relevance
“…All compounds have been tested to establish their P‐gp interacting mechanism by evaluating: (i) the inhibition of calcein‐AM probe in MDCK cells overexpressing P‐gp ; (ii) apparent permeability determination ( P app ) in Caco‐2 cells monolayer . The first assay allows to define the potency of the interaction of each compound toward P‐gp; the second assay permits to distinguish between an inhibitor ( P app < 2) or a substrate ( P app > 2) .…”
Section: Resultsmentioning
confidence: 99%
“…All compounds have been tested to establish their P‐gp interacting mechanism by evaluating: (i) the inhibition of calcein‐AM probe in MDCK cells overexpressing P‐gp ; (ii) apparent permeability determination ( P app ) in Caco‐2 cells monolayer . The first assay allows to define the potency of the interaction of each compound toward P‐gp; the second assay permits to distinguish between an inhibitor ( P app < 2) or a substrate ( P app > 2) .…”
Section: Resultsmentioning
confidence: 99%
“…-(3-((4-phenyl-1,2,5-oxadiazol-3-yl) (quin, J = 5.9 Hz, 2H). 13 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 …”
Section: Methodsmentioning
confidence: 99%
“…26 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 solubilized using 100 µL of DMSO and the absorbance values at 570 and 630 nm were determined on the microplate reader Victor3 from PerkinElmer Life Sciences.…”
Section: -Methoxy-4-(phenylsulfonylmentioning
confidence: 99%
See 1 more Smart Citation
“…THIQ) is as tructuralk ey element of elacridar andt ariquidar (two P-gp saturating substrates or inhibitor-like compounds). [13][14][15][16] Indomethacin, P6, and mofezolac were then linked to either aR h6Go r6 ,7-DM-THIQm oiety to first explore the COX inhibitor recognitiona nd,s econdly, to verify if such new molecules retain P-gp substrate/inhibitor activity.…”
Section: Introductionmentioning
confidence: 99%